Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation
Diabetologia · 2024-10 · 67 (10) · 2329-2345
DOI: 10.1007/s00125-024-06215-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, online erschienen am 08.07.2024. Verfasst von Muneo Yamaguchi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Macrophages, Microglia, Diabetic Retinopathy, Ischemia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: JSPS KAKENHI, Takeda Science Foundation, Bayer Retina Award.
Abstract (Originalsprache)
AIMS/HYPOTHESIS: Diabetic retinopathy is characterised by neuroinflammation that drives neuronal and vascular degenerative pathology, which in many individuals can lead to retinal ischaemia and neovascularisation. Infiltrating macrophages and activated retina-resident microglia have been implicated in the progression of diabetic retinopathy, although the distinct roles of these immune cells remain ill-defined. Our aim was to clarify the distinct roles of macrophages/microglia in the pathogenesis of proliferative ischaemic retinopathies. METHODS: Murine oxygen-induced retinopathy is commonly used as a model of ischaemia-induced proliferative diabetic retinopathy (PDR). We evaluated the phenotype macrophages/microglia by immunostaining, quantitative real-time RT-PCR (qRT-PCR), flow cytometry and scRNA-seq analysis. In clinical imaging studies of diabetic retinopathy, we used optical coherence tomography (OCT) and OCT angiography. RESULTS: Immunostaining, qRT-PCR and flow cytometry showed expression levels of M1-like macrophages/microglia markers (CD80, CD68 and nitric oxide synthase 2) and M2-like macrophages/microglia markers (CD206, CD163 and macrophage scavenger receptor 1) were upregulated in areas of retinal ischaemia and around neo-vessels, respectively. scRNA-seq analysis of the ischaemic retina revealed distinct ischaemia-related clusters of macrophages/microglia that express M1 markers as well as C-C chemokine receptor 2. Inhibition of Rho-kinase (ROCK) suppressed CCL2 expression and reduced CCR2-positive M1-like macrophages/microglia in areas of ischaemia. Furthermore, the area of retinal ischaemia was reduced by suppressing blood macrophage infiltration not only by ROCK inhibitor and monocyte chemoattractant protein-1 antibody but also by GdCl3. Clinical imaging studies of diabetic retinopathy using OCT indicated potential involvement of macrophages/microglia represented by hyperreflective foci in areas of reduced perfusion. CONCLUSIONS/INTERPRETATION: These results collectively indicated that heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation in retinal vascular diseases including diabetic retinopathy. This adds important new information that could provide a basis for a more targeted, cell-specific therapeutic approach to prevent progression to sight-threatening PDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
- Department of Ophthalmology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
- Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
- Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan. s.nakao.dk@juntendo.ac.jp.
- Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Förderung
- JSPS KAKENHI
- Takeda Science Foundation
- Bayer Retina Award
- The Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder
- Alcon Pharma Research Grants
- The Foundation for The Advancement of Clinical Medicine
- Novartis Pharma Research Grants
Zitieren
APA
Yamaguchi, M., Nakao, S., Arima, M., Little, K., Singh, A., Wada, I., Kaizu, Y., Zandi, S., Garweg, J. G., Matoba, T., Shiraishi, W., Yamasaki, R., Shibata, K., Go, Y., Ishibashi, T., Uemura, A., Stitt, A. W., & Sonoda, K. H. (2024). Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation. Diabetologia, 67(10), 2329-2345. https://doi.org/10.1007/s00125-024-06215-3
Vancouver
Yamaguchi M, Nakao S, Arima M, Little K, Singh A, Wada I, et al. Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation. Diabetologia. 2024;67(10):2329-2345. doi:10.1007/s00125-024-06215-3
BibTeX
@article{Yamaguchi2024,
author = {Yamaguchi, Muneo and Nakao, Shintaro and Arima, Mitsuru and Little, Karis and Singh, Aditi and Wada, Iori and Kaizu, Yoshihiro and Zandi, Souska and Garweg, Justus G and Matoba, Tetsuya and Shiraishi, Wataru and Yamasaki, Ryo and Shibata, Kensuke and Go, Yasuhiro and Ishibashi, Tatsuro and Uemura, Akiyoshi and Stitt, Alan W and Sonoda, Koh-Hei},
title = {Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation},
journal = {Diabetologia},
year = {2024},
volume = {67},
number = {10},
pages = {2329--2345},
doi = {10.1007/s00125-024-06215-3}
}
EUVIMED